Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Reeves

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Cancer|January 18, 2017
Phase 2, randomized, double-blind study of pracinostat in combination with azacitidine in patients with untreated, higher-risk myelodysplastic syndromesGuillermo Garcia-Manero, Guillermo Montalban-Bravo, Jesus G Berdeja, et al.
European Urology|March 8, 2021
Efficacy and Safety of Atezolizumab Plus Bevacizumab Following Disease Progression on Atezolizumab or Sunitinib Monotherapy in Patients with Metastatic Renal Cell Carcinoma in IMmotion150: A Randomized Phase 2 Clinical TrialThomas Powles, Michael B Atkins, Bernard Escudier, et al.
The New England Journal of Medicine|August 23, 2013
Pazopanib versus sunitinib in metastatic renal-cell carcinomaRobert J Motzer, Thomas E Hutson, David Cella, et al.
The Bone & Joint Journal|May 31, 2026
Infection following foot and ankle surgery : a subanalysis of data captured from the UK Foot and Ankle Thromboembolism (FATE) auditJenna Shepherd, Lyndon Mason, Linzy Houchen-Wolloff, et al.
The Bone & Joint Journal|October 31, 2024
UK Foot and Ankle Thromboembolism (UK-FATE)Jitendra Mangwani, Linzy Houchen-Wolloff, Karan Malhotra, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Cancer|January 18, 2017
Phase 2, randomized, double-blind study of pracinostat in combination with azacitidine in patients with untreated, higher-risk myelodysplastic syndromesGuillermo Garcia-Manero, Guillermo Montalban-Bravo, Jesus G Berdeja, et al.
European Urology|March 8, 2021
Efficacy and Safety of Atezolizumab Plus Bevacizumab Following Disease Progression on Atezolizumab or Sunitinib Monotherapy in Patients with Metastatic Renal Cell Carcinoma in IMmotion150: A Randomized Phase 2 Clinical TrialThomas Powles, Michael B Atkins, Bernard Escudier, et al.
The New England Journal of Medicine|August 23, 2013
Pazopanib versus sunitinib in metastatic renal-cell carcinomaRobert J Motzer, Thomas E Hutson, David Cella, et al.
The Bone & Joint Journal|May 31, 2026
Infection following foot and ankle surgery : a subanalysis of data captured from the UK Foot and Ankle Thromboembolism (FATE) auditJenna Shepherd, Lyndon Mason, Linzy Houchen-Wolloff, et al.
The Bone & Joint Journal|October 31, 2024
UK Foot and Ankle Thromboembolism (UK-FATE)Jitendra Mangwani, Linzy Houchen-Wolloff, Karan Malhotra, et al.
Pageof 4